Welcome to the e-CCO Library Archive!

Filter:
P130. Correlation between serological biomarkers and clinical activity in patients with inflammatory bowel disease (IBD)
P130. Terminal ileitis: Not always Crohn's
P130. The quality of inflammatory bowel disease inpatient experience: data from the UK IBD Audit
Authors:

K. Bodger1, R. Driscoll2, A. Protheroe3, M. Roughton3, I. Arnott4, 1University of Liverpool, Liverpool, United Kingdom, 2Crohn's and Colitis UK, United Kingdom, 3Royal College of Physicians, CEEu, London, United Kingdom, 4Western General Hospital, Gastrointestinal Unit, Edinburgh, United Kingdom

P130

Persistent Enhancement in Contrast Ultrasound Studies of Severe Crohn's Disease: Stuck Bubbles?

Authors:

R. Wilkens*1, 2, 3, 4, A. Wilson1, P.N. Burns5, S. Ghosh2, S.R. Wilson1, 2

1University of Calgary, Department of Radiology, Calgary, Canada, 2University of Calgary, Department of Medicine, Division of Gastroenterology, Calgary, Canada, 3Regional Hospital Silkeborg, University Research Clinic for Innovative Patient Pathways, Diagnostic Center, Division of Gastroenterology, Silkeborg, Denmark, 4Aarhus University Hospital, Department of Hepatology and Gastroenterology, Aarhus, Denmark, 5University of Toronto, Department of Biophysics and Imaging Research, Toronto, Canada

P131.

Systematic analysis of factors associated with progression and regression of ulcerative colitis in the Swiss IBD Cohort study

Authors:

E. Safroneeva1, S. Vavricka2, N. Fournier3,4, F. Seibold5, C. Mottet6, A. Straumann7, G. Rogler2, A. Schoepfer6, 1University of Bern, Institute of Social and Preventive Medicine, Bern, Switzerland, 2University of Zurich, Gastroenterology and Hepatology, Zurich, Switzerland, 3Institute of Social and Preventive Medicine, Healthcare Evaluation Unit, Lausanne, Switzerland, 4University of Lausanne, IUMSP, Lausanne, Switzerland, 5University Hospital Bern, Gastroenterology and Hepatology, Bern, Switzerland, 6University of Lausanne, Gastroenterology and Hepatology, Lausanne, Switzerland, 7University of Basel, Gastroenterology and Hepatology, Basel, Switzerland

P131. Anal ulceration in Crohn's disease: Natural history at the time of biotherapy
P131. The lack of CRP response in patients with non-colonic active Crohn's disease
P131. The minimal role of enema preparation for sigmoidoscopy in active ulcerative colitis patients
Authors:

E.S. Kim1, Y.T. Jeen1, B. Keum1, B.J. Lee1, J.S. Koo1, R.S. Choung1, J.H. Choi1, 1Korea University College of Medicine, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Seoul, South Korea

P131

High prevalence of Inflammatory Bowel Disease like findings in endoscopic and pathological samples of patients with common variable immunodeficiency

Authors:

S. Fernandes*1, C. Moura1, C. Baldaia1, S. Silva2, S. Lopes Silva2, L. Correia1, M. Barbosa2, J. Velosa1

1Centro Hospitalar Lisboa Norte, Gastrenterology, Lisbon, Portugal, 2Centro Hospitalar Lisboa Norte, Imunoalergologia, Lisbon, Portugal

P132.

Study of intestinal parasitic infections and risk factors among patients suffering from inflammatory bowel disease in Alexandria, Egypt

Authors:

F.I.M. Hassanein3, Z.M. Shaibat El-Hamd2, S.A. El-Masry2, E.A. Ahmed1, A.A. Hassan2, 1Alexandria university, Internal medicine-gastroenterology unit, Alexandria, Egypt, 2High Institute of Public Health, Department of Tropical Health, Parasitology and Medical Entomology, Alexandria, Egypt, 3Faculty of Pharmacy and Drug Manufacturing-Pharos University, Microbiology and Immunology, Alexandria, Egypt

P132. Links between anal and luminal phenotypes in Crohn's disease
P132. The level of serum C-reactive protein as a predictive marker of recurrence after ileo-colonic resection for Crohn's disease. Results of a longitudinal prospective study
Authors:

E. Iaculli1, T. Giorgia2, C. Fiorani2, O. Sara2, L. Biancone3, R. Scaramuzzo3, R. Pezzuto3, A.L. Gaspari2, G. Sica2, 1Guy's and St Thomas' Hospital, Surgery, London, United Kingdom, 2Tor Vergata Roma, Italy, 3Tor Vergata, Italy

P132. Thromboembolic complications in inflammatory bowel disease patients: Prevalence in a tertiary referral center
P132

Could the cytokines concentration be a marker of IBD activity and be usefull in evaluation of IBD differentiation?

Authors:

I. Ciecko-Michalska*1, I. Wierzbicka-Tutka2, M. Szczepanek3, D. Fedak4, T. Mach5

1Jagiellonian University Medical College, Department of Gastroenterology ang Hepatology, Krakow, Poland, 2University Hospital, Department of Gastroenterology and Hepatology, Krakow, Poland, 3Jagiellonian University Medical College, Department of Gastroenterology and Hepatolgy, Krakow, Poland, 4Jagiellonian University Medical College, Department of Clinical Biochemistry, Krakow, Poland, 5Jagiellonian University Medical College, Department of Gastroenterology and Hepatology, Krakow, Poland

P133.

Small bowel stricture in Crohn's disease: The main factor for surgery indication?

Authors:

G. Vincoli1, L. Candeloro1, R. Calarco1, E. Corazziari1, N. Pallotta1, 1“Sapienza”, Department of Internal Medicine and Medical Specialties, Rome, Italy

P133. Fecal calprotectin and CRP as biomarkers of endoscopic activity in Crohn's disease: A meta-study
P133. K-ras, Cox-2 and membrane β-catenin positivity are characteristics of tumor-free mucosa in patients with ulcerative colitis-associated colorectal cancer
P133. The incidence of IgG4-positive plasma cell mediated colitis in the absence of autoimmune pancreatitis
Authors:

E. Saritas Yuksel1, B. Unsal1, Z. Akpinar1, S. Gunay1, N. Ekinci2, F. Unay2, 1Izmir Ataturk Teaching and Research Hospital, Gastroenterology, Izmir, Turkey, 2Izmir Ataturk Teaching and Research Hospital, Pathology, Izmir, Turkey

P133

Frequency of fecal incontinence and factors associated with its development in patients with Inflammatory Bowel Disease

Authors:

F. Gonzalez-Ortiz*, N. Bueno-Hernandez, J. Yamamoto-Furosho

IBD Clinic, Instituto Nacional de Ciencias Medicas y Nutricion, Gastroenterology, Mexico, Mexico

P134.

Small bowel prestenotic dilatation is not related to severity degree of stricture and to surgical indication in Crohn's disease (CD) patients

Authors:

G. Vincoli1, L. Candeloro1, R. Calarco1, E. Corazziari1, N. Pallotta1, 1“Sapienza”, Department of Internal Medicine and Medical Specialties, Rome, Italy